Dr. XU Mingbo is the founder, chairman and CEO of Beijing SL Pharmaceutical Co., Ltd. As one of the first Chinese companies to successfully develop and commercialize recombinant products in the 1990s, SL Pharm has grown into a publicly traded Chinese pharma with businesses in biologics as well as chemical entities, with annual sales reaching $300 million USD. Over the years, Dr. Xu and his team have published a dozen patents and over 50 papers, and the company has received multiple national level awards for its technological breakthroughs. He brings to Diapin deep manufacturing expertise as well as three decades of commercialization experiences in the global pharmaceutical industry.